These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24252474)

  • 21. Plasminogen and plasmin in Alzheimer's disease.
    Barker R; Love S; Kehoe PG
    Brain Res; 2010 Oct; 1355():7-15. PubMed ID: 20709033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
    Iwamoto M
    Thromb Diath Haemorrh; 1975 Jun; 33(3):573-85. PubMed ID: 125463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasmin.
    de Souza LR; M Melo P; Paschoalin T; Carmona AK; Kondo M; Hirata IY; Blaber M; Tersariol I; Takatsuka J; Juliano MA; Juliano L; Gomes RA; Puzer L
    Biochem Biophys Res Commun; 2013 Apr; 433(3):333-7. PubMed ID: 23500465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the native plasminogen reveals an activation-resistant compact conformation.
    Xue Y; Bodin C; Olsson K
    J Thromb Haemost; 2012 Jul; 10(7):1385-96. PubMed ID: 22540246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM).
    Figuera-Losada M; Ranson M; Sanderson-Smith ML; Walker MJ; Castellino FJ; Prorok M
    Biochim Biophys Acta; 2010 Jun; 1804(6):1342-9. PubMed ID: 20152941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
    Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
    Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative selectivity and the evolution of protease cascades: the specificity of plasmin for peptide and protein substrates.
    Hervio LS; Coombs GS; Bergstrom RC; Trivedi K; Corey DR; Madison EL
    Chem Biol; 2000 Jun; 7(6):443-53. PubMed ID: 10873836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potent anti-fibrinolytic compounds against plasminogen and tissue-type plasminogen activator employing
    Banerjee S; Mahesh Y; Prabhu D; Sekar K; Sen P
    J Biomol Struct Dyn; 2024 Apr; 42(6):3204-3222. PubMed ID: 37216286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study on the inhibition of plasmin and delta-plasmin via benzamidine derivatives.
    Alves NJ; Kline JA
    Biochem Biophys Res Commun; 2015 Feb; 457(3):358-62. PubMed ID: 25576865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactoferrin is a natural inhibitor of plasminogen activation.
    Zwirzitz A; Reiter M; Skrabana R; Ohradanova-Repic A; Majdic O; Gutekova M; Cehlar O; Petrovčíková E; Kutejova E; Stanek G; Stockinger H; Leksa V
    J Biol Chem; 2018 Jun; 293(22):8600-8613. PubMed ID: 29669808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and function of the plasminogen/plasmin system.
    Castellino FJ; Ploplis VA
    Thromb Haemost; 2005 Apr; 93(4):647-54. PubMed ID: 15841308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capturing host plasmin(ogen): a common mechanism for invasive pathogens?
    Lottenberg R; Minning-Wenz D; Boyle MD
    Trends Microbiol; 1994 Jan; 2(1):20-4. PubMed ID: 8162432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of reduction of disulfide bonds in plasmin by phosphoglycerate kinase.
    Lay AJ; Hogg PJ
    Methods Enzymol; 2002; 348():87-92. PubMed ID: 11885297
    [No Abstract]   [Full Text] [Related]  

  • 37. Experience with plasmin inhibitors.
    Tervo T; van Setten GB; Tervo K; Tarkkanen A
    Acta Ophthalmol Suppl (1985); 1992; (202):47-53. PubMed ID: 1322011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel aspects and new roles for the serine protease plasmin.
    Syrovets T; Simmet T
    Cell Mol Life Sci; 2004 Apr; 61(7-8):873-85. PubMed ID: 15095009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of inhibitory (anti-catalytic) antibodies to study extracellular proteolysis.
    Birkedal-Hansen H; Birkedal-Hansen B; Windsor LJ; Lin HY; Taylor RE; Moore WG
    Immunol Invest; 1989; 18(1-4):211-24. PubMed ID: 2543625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The detection of capability of Vibrio comma to activate human plasminogen in vitro].
    Shipko ES; Mishan'kin BN; Duvanova OV; Romanova LV; Shimaniuk NIa; Vodop'ianov SO
    Klin Lab Diagn; 2012 Nov; (11):57-9. PubMed ID: 23305022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.